Moxifloxacin more favorable than amoxicillin/clavulanate for COPD exacerbations

Links shared publicly online about this topic.

1,440
total visits

Moxifloxacin more favorable than amoxicillin/clavulanate for COPD exacerbations

Chronic obstructive pulmonary disease (COPD) affects a large number of subjects worldwide and is characterised by a progressively rising epidemiological, clinical and socio-economic impact. The objectives of treatment are to decrease the burden of the disease through relief of symptoms, improvement of exercise tolerance, and prevention and treatment of exacerbations.

View full resource at news-medical.net

Tags: COPD, Disease and Condition, Antibiotic, Avelox, Avalox, Pulmonology